← All organizations
inVentiv
For profitContributed to NME
Also known as: INC Research/InVentiv Health | InVentiv Clinique | Inventiv Health | inVentiv Health Clinical | inVentiv Health Clinical (iVH) | InVentiv Health Clinical Research Services | inVentiv Health Clinical Research Services LLC | inVentiv Health Clinical Research Services,LLC | inVentiv Health Clinique
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2011Last known activity
Jan 28, 2019
Acquired by Syneos Health on May 10, 2017
Timeline
1980s
- Jan 1, 1984
inVentiv— Founded
2000s
- Nov 22, 2004
HHI Clinical Research— Acquired
2010s
- May 18, 2011
PharmaNet (2006)— Acquired
- Mar 19, 2012
Kforce— Acquired
- May 10, 2017
Syneos Health— Acquired By
Drugs by trial phase (44 distinct, 55 trials)
Phase 4 (0 own, 1 via acquisition)
Phase 3 (4 own, 1 via acquisition)
Phase 2 (14 own, 3 via acquisition)
Phase 1 (6 own, 15 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Amyotrophic Lateral Sclerosis
- Cholangitis
- Cholangitis, Sclerosing
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Conjunctivitis
- Epilepsy
- Fibromyalgia
- Hemorrhage
- Hypogonadism
- Hypovolemia
- Infections
- Influenza, Human
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Motor Neuron Disease
- Multiple Myeloma
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myofascial Pain Syndromes
- Neoplasms
- Neoplasms, Plasma Cell
- Pancreatic Neoplasms
- Postpartum Hemorrhage
- Rabies
- Respiratory Tract Diseases
- Respiratory Tract Infections
- RNA Virus Infections
- Sclerosis
- Ulcer
- Virus Diseases
Subsidiaries (3 direct, 4 total across the full acquisition tree)
Recent trials (26)
- NCT04984707Overall official - principal investigatorPhase 1Jan 28, 2019
- NCT03679975CollaboratorPhase 2Apr 4, 2018
- NCT03457753CollaboratorPhase 2Mar 31, 2018
- NCT03428360CollaboratorPhase 3Jan 23, 2018
- NCT03394781Study directorPhase 2Jan 22, 2018
- NCT03222349CollaboratorPhase 2Aug 31, 2017
- NCT03249103CollaboratorPhase 2Aug 14, 2017
- NCT03179891CollaboratorPhase 2Jun 12, 2017
- NCT02851797CollaboratorPhase 3Apr 1, 2017
- NCT03206229CollaboratorPhase 1Feb 13, 2017
- NCT02999100CollaboratorPhase 1Nov 23, 2016
- NCT02956746CollaboratorPhase 1/Phase 2Aug 1, 2016
- NCT02956746Overall official - principal investigatorPhase 1/Phase 2Aug 1, 2016
- NCT02853643Overall official - principal investigatorPhase 1Jul 1, 2016
- NCT02493712CollaboratorPhase 2Jan 1, 2016
Details
- Founded
- Princeton, NJ, US Jan 1, 1984
- Last known activity
- Jan 28, 2019